DNA helicases are essential enzymes that regulate nearly every aspect of DNA metabolism, including replication, repair, recombination, and transcription. Their dysregulation is linked to a wide range of diseases, making them attractive therapeutic targets. In cancer, certain DNA helicases support tumor growth and genomic instability by promoting rapid DNA replication and enabling tumor cells to tolerate DNA damage.
In viral infections, both host and viral DNA helicases play key roles in viral genome replication, offering unique points of therapeutic intervention. DNA helicase dysfunction is also implicated in neurodegenerative diseases, premature aging syndromes, immunodeficiencies, and rare genetic disorders due to impaired genome maintenance and DNA damage responses.
Targeting DNA helicases with small-molecule inhibitors or nucleic acid–based therapies holds promise for developing more precise treatments across multiple disease areas.